Literature DB >> 16226351

Association of interleukin-1 gene polymorphisms with dementia in a community-based sample: the Honolulu-Asia Aging Study.

Berran Yucesoy1, Rita Peila, Lon R White, Kim Ming Wu, Victor J Johnson, Michael L Kashon, Michael I Luster, Lenore J Launer.   

Abstract

The interleukin-1 (IL-1) pro-inflammatory cytokine family participates in inflammatory processes and vessel damage involved in neurodegeneration. Recent studies suggest that Alzheimer's disease (AD) and vascular dementia (VaD) may share genetic risk factors. In this study, the frequency of polymorphisms in the genes coding for interleukin (IL)-1alpha, IL-1beta and the IL-1 receptor antagonist (RN) and their genotype associations with late-onset AD and VaD were determined in a Japanese-American cohort of men (n=931) participating in the Honolulu-Asia Aging Study (HAAS). A significant association was found between the IL-1beta (-511) and IL-1RN (+2018) polymorphisms and AD, suggesting that these variants confer an increased risk. Possessing the IL-1beta (-511) T/T genotype was also associated with VaD. There was no difference in the IL-1beta (+3953) frequency among the groups. Our results support the hypothesis that certain genetic variations contained within the IL-1 gene family contribute to the pathogenesis of dementia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16226351     DOI: 10.1016/j.neurobiolaging.2005.01.013

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  13 in total

1.  Neuroinflammatory Cytokines-The Common Thread in Alzheimer's Pathogenesis.

Authors:  W Sue T Griffin; Steven W Barger
Journal:  US Neurol       Date:  2010

Review 2.  Genetic influences on outcome following traumatic brain injury.

Authors:  Barry D Jordan
Journal:  Neurochem Res       Date:  2007-03-07       Impact factor: 3.996

3.  Interleukin 18 gene polymorphisms predict risk and outcome of Alzheimer's disease.

Authors:  Paola Bossù; Antonio Ciaramella; Maria Luisa Moro; Lorenza Bellincampi; Sergio Bernardini; Giorgio Federici; Alberto Trequattrini; Fabio Macciardi; Ilaria Spoletini; Fulvia Di Iulio; Carlo Caltagirone; Gianfranco Spalletta
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-02-13       Impact factor: 10.154

4.  Association between interleukin-6 gene promoter -572C/G polymorphism and the risk of sporadic Alzheimer's disease.

Authors:  Mei-xia He; Wan-li Yang; Ming-ming Zhang; Ya-jun Lian; Hai-ying Hua; Jin-sheng Zeng; Li-rong Zhang
Journal:  Neurol Sci       Date:  2009-12-03       Impact factor: 3.307

Review 5.  Inflammatory Cytokines and Alzheimer's Disease: A Review from the Perspective of Genetic Polymorphisms.

Authors:  Fan Su; Feng Bai; Zhijun Zhang
Journal:  Neurosci Bull       Date:  2016-08-27       Impact factor: 5.203

6.  Genetic polymorphism of interleukin 1β -511C/T and susceptibility to sporadic Alzheimer's disease: a meta-analysis.

Authors:  Hai Yuan; Qing Xia; Pingping Ge; Shaowei Wu
Journal:  Mol Biol Rep       Date:  2012-10-19       Impact factor: 2.316

7.  Interleukin-1 alpha polymorphism has influence on late-onset sporadic Parkinson's disease in Taiwan.

Authors:  Y R Wu; C M Chen; J C Hwang; S T Chen; I H Feng; H C Hsu; C N Liu; Y T Liu; Y Y Lai; H J Huang; G J Lee-Chen
Journal:  J Neural Transm (Vienna)       Date:  2007-04-26       Impact factor: 3.575

8.  Association of adiposity status and changes in early to mid-adulthood with incidence of Alzheimer's disease.

Authors:  May A Beydoun; April Lhotsky; Youfa Wang; Gloria Dal Forno; Yang An; E Jeffrey Metter; Luigi Ferrucci; Richard O'Brien; Alan B Zonderman
Journal:  Am J Epidemiol       Date:  2008-10-03       Impact factor: 4.897

9.  Evaluation of inflammation-related genes polymorphisms in Mexican with Alzheimer's disease: a pilot study.

Authors:  Danira Toral-Rios; Diana Franco-Bocanegra; Oscar Rosas-Carrasco; Francisco Mena-Barranco; Rosa Carvajal-García; Marco Antonio Meraz-Ríos; Victoria Campos-Peña
Journal:  Front Cell Neurosci       Date:  2015-05-18       Impact factor: 5.505

10.  Panel of Genetic Variations as a Potential Non-invasive Biomarker for Early Diagnosis of Alzheimer's Disease.

Authors:  Suk Ling Ma; Linda Chiu Wa Lam
Journal:  Clin Psychopharmacol Neurosci       Date:  2011-08-31       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.